Device for the controlled release of ablative energy to tissue using a pulsed electric field

DE602019079464T2Active Publication Date: 2025-12-17BOSTON SCIENTIFIC SCIMED INC
0 Cites 0 Cited by

Patent Information

Application Number
DE602019079464
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-02-08
Filing Date
2019-02-08
Publication Date
2025-12-17
Estimated Expiration
2039-02-08

AI Technical Summary

Technical Problem

Existing methods for delivering pulsed electric fields for tissue therapeutics lack controlled and selective energy delivery, particularly in ablation therapy for cardiac arrhythmias, and there is a need for measured and controlled delivery of high voltage application to ensure safety and efficacy.

Method used

A system with a multi-channel voltage/signal generator and programmable controller applies voltage pulses to selected electrodes, using hierarchical waveforms and adaptive current control to ensure safe and effective irreversible electroporation, synchronized with cardiac pacing to avoid disrupting sinus rhythm.

Benefits of technology

The system enhances safety and efficiency of energy delivery by reducing the electric field threshold for irreversible electroporation, creating effective ablative lesions with reduced total energy, while minimizing damage to healthy tissue.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.